Breakthrough diabetes drug slashes dementia risk by 35%
A groundbreaking development in diabetes treatment reveals that SGLT-2 inhibitors significantly reduce dementia risk among type 2 diabetes patients. Recent research demonstrates these medications offer
January 26, 2025
No Comments
